Department of Intellectual Property Explaining drug precursor “Favipiravir” never received a patent application.

29 April 2021 – 22:15

Department of Intellectual Property Explain drug precursor “Favipiravier” has never received a patent application. Manufacturers can add substances to the production. As for the tablets, there are additional procurement options.

Mr. Wuttikrai Lee Viraphan, Director-General, Department of Intellectual Property Ministry of Commerce Revealed in the case that civil society asks the progress of the patent application, Favipiravir, an important drug used in the treatment of COVID-19, that patents related to Favipiravia There are two main lines, one of which deals with the drug’s main active ingredient structure, which has never been filed for a patent in Thailand. Coverage is now expired in all countries around the world. Since August 2019, drug manufacturers can immediately develop the structural formula of this main active ingredient into a drug formulation for medical use. Part 2, the patent application of favipiravir in tablet form. Which has submitted a request to the Department of Intellectual Property to examine the invention on September 4, 2017 and the inspectors have considered it. Therefore, a letter notifying the applicant’s audit results on February 2, 2021 stating that the patent does not have a higher level of invention. The applicant has a time frame to clarify this 30 August. However, if the applicant does not clarify in the specified time. Will be considered to abandon the application under Section 27 of the Patent Act

However, the Department has discussed with relevant agencies, including civil society. To prepare adequate amounts of the drug in the event of a re-epidemic situation. Therefore proposed a way to negotiate to purchase additional drugs Including requesting a joint investment in production with a patent applicant in Thailand To make Thailand a production base in the region, it is also discussed the possibility of developing a new product based on the non-patented active ingredient in Thailand. This can be done immediately without waiting for the results of the patent application in the pill form of Favipiravir. By doing all steps in accordance with the process of the law. And has been carefully considered

You can follow great content like this at

Facebook: https://www.facebook.com/innnews.co.th

Twitter: https://twitter.com/innnews

Youtube: https://www.youtube.com/c/INNNEWS_INN

TikTok: https://www.tiktok.com/@inn_news